Mazoteras Pardo, VictoriaBecerro de Bengoa Vallejo, RicardoLosa Iglesias, Marta ElenaMartínez Jiménez, Eva MaríaCalvo Lobo, César Romero Morales, CarlosLópez López, DanielPalomo López, Patricia2020-10-202020-10-202020Mazoteras-Pardo, V., Becerro-de-Bengoa-Vallejo, R., Losa-Iglesias, M. E., Martínez-Jiménez, E. M., Calvo-Lobo, C., Romero-Morales, C., López-López, D., & Palomo-López, P. (2020). QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study. Journal of Medical Internet Research, 22(7), e19781. https://doi.org/10.2196/197811439-44561438-8871http://hdl.handle.net/11268/9165Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.engAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/journal article10.2196/19781open accessHipertensiónDiabetesTecnología médicaSistema cardiovascularEnfermedad cardiovascularTecnología médica